Kanjinti | 合法藥品大搜索

KANJINTI® (Trastuzumab). 中文品名: 康癌停凍晶注射劑420毫克英文品名: KANJINTI Powder for concentrate for solution for infusion 420mg 主成分: Trastuzumab Read More

KANJINTI is indicated for the treatment of adult patients with HER2 positive early breast cancer. (EBC):. - following surgery, chemotherapy (neoadjuvant or ... Read More

2018年5月16日 — Overview. Kanjinti is a cancer medicine used to treat the following conditions: ... Kanjinti can only be used when the cancer 'overexpresses HER2': ... Read More

2020年12月18日 — Additional information: Kanjinti is a biosimilar of Herceptin. Herceptin is a monoclonal antibody, “biologic” drug. This means that it is made from ... Read More

Do not substitute KANJINTI (trastuzumab-anns) for or with ado-trastuzumab emtansine. Adjuvant Treatment, Breast Cancer: Administer according to one of the ... Read More

KANJINTI™ is indicated, in combination with cisplatin and capecitabine or 5-fluorouracil, for the treatment of patients with HER2 overexpressing metastatic gastric ... Read More

KANJINTI in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of adult patients with HER2 positive metastatic ... Read More

KANJINTI is used to treat breast and gastric cancer. It is only used in patients whose tumour has tested positive to HER2. KANJINTI may be used alone or with ... Read More

KANJINTI is indicated, in combination with cisplatin and capecitabine or 5-fluorouracil, for the treatment of patients with HER2 overexpressing metastatic gastric or ... Read More